Twenty-four-hour simultaneous subcutaneous Basal-bolus administration of insulin and amylin in adolescents with type 1 diabetes decreases postprandial hyperglycemia.

Source:http://linkedlifedata.com/resource/pubmed/id/19190104

Download in:

View as

General Info

PMID
19190104